Provider P39-16 Expansion of Drug-Related Xenazine Prior Authorization Criteria with Quantity Limit to Minnesota Health Care Programs Read More
Provider P40-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Lidocaine Transdermal Read More
Provider P57-16 Change in Medical Policy and Commercial Benefit Coverage of CT Colonography Colorectal Cancer Screening Test Read More
Provider P37-16 Addition of a Drug (Epclusa) to the Hepatitis C Second Generation Prior Authorization with Quantity Limit Program Read More
Provider P24-17 AOR No Longer Required for Submission of Organization Determinations for Platinum Blue Subscribers Read More
Provider P11R1-17 Revised: Pre-Admission Notification Requirement for Admissions effective June 1, 2017 Read More
Provider P27R1-16 Revised: Changes to Prior Authorization Requirements for Select Services for Commercial Products Read More
